The National Ayush Mission (NAM) Conclave 2025 continued with its second day, focusing on enhancing the quality of services under Ayush facilities through improved standards and systems. Comprehensive discussions highlighted Indian Public Health Standards (IPHS) implementation for Ayushman Arogya Mandir (AAM) and Ayush hospitals, aiming for compliance increases by specific dates leading up to 2029. Dr. Mahesh Kumar Dadhich from the National Medicinal Plants Board discussed the essential role of medicinal plants in conservation, biodiversity maintenance, and climate change mitigation under a central scheme.
Session V addressed regulatory challenges with ensuring uniform implementation across states and strengthening coordination between central and state authorities for quality assurance of Ayush medicines and advertisement monitoring. The discussion covered strategies for combating misleading advertisements through pharmacovigilance programs.
Finally, the day explored investment opportunities in the Ayush sector. It was noted that the sector experienced significant growth from $2.85 billion in 2014 to $23 billion by 2023 in manufacturing and projected further ambitions toward realizing a target of $200 billion by 2030.
Leaderships from various states shared best practices and innovations related to Ayush healthcare delivery, highlighting their initiatives on integrating traditional knowledge with modern technology. The NAM Conclave serves as a platform for policy discussions that are instrumental in strengthening the Ayush health care system across India.
Key Entities Referenced
AYUSH: An acronym for Ayurveda, Yoga, Unani, Siddha, and Homeopathy, representing India's traditional systems of medicine.
NAM Conclave: The second edition of the National Ayush Mission annual conference, held in Lonavala, focused on quality standards, regulation, and investment opportunities for the Ayush sector.
National Ayush Mission (NAM): A governmental initiative launched in 2014 to integrate traditional Indian medicine systems into mainstream healthcare, aiming to enhance services through initiatives like Ayushman Arogya Mandir Ayush under Ayushman Bharat scheme.
International Public Health Standards (IPHS): Stipulated standards for Ayushman Arogya Mandir Ayush and Ayush hospitals, with a goal of 30% compliance by June 2026, increasing to 40% by 2028 and 50% by 2029.
National Medicinal Plants Board (NMPB): A board outlining the role of medicinal plants in conservation, biodiversity, and climate change mitigation through a Central Sector Scheme.
Ayush Grid: A dedicated digital platform aiming to improve operational efficiency and service delivery within the Ayush sector.
Pharmacovigilance program: A strategy under Dr. Galib's discussion on regulatory mechanisms aimed at monitoring misleading advertisements in the Ayush sector.
Ministry of Ayush: Government Ministry responsible for managing and regulating traditional systems of medicine within India.
NABH (National Accreditation Board for Hospitals & Health Care Providers): A body that provides accreditation to ensure quality standards in Ayush facilities, leading to certification of health and wellness centers along with integrated Ayush hospitals.
STGs (Standard Treatment Guidelines): Guidelines on specific metabolic disorders included as part of the Ayush systems, covering areas like Diabetes Mellitus, Obesity, Gout, NonAlcoholic Fatty Liver Disease (NAFLD), and Dyslipidemia.
AYUSH
States and UTs Conclude Day-2 of NAM Conclave
with Renewed Push for Public Health Delivery
Experiential knowledge exchange and constructive
deliberations inspire fresh momentum in Ayush
quality standards, regulation, and investment
Posted On: 02 MAY 2025 6:26PM by PIB Mumbai
Pune/Mumbai, 2 May 2025
LONAVALA, MAHARASHTRA - Day-2 of the second edition of National Ayush Mission (NAM)
Conclave 2025, being held at Kaivalyadhama, Lonavala, featured comprehensive discussions on
enhancing quality services under Ayush facilities, strengthening regulatory mechanisms, and
exploring investment opportunities in the Ayush sector.
The day began with Session IV on "Quality Services Under Ayush Facilities Including Medicinal
Plants," coordinated by Dr. A. Raghu, DDG (Ayush), Ayush Vertical DGHS. The session highlighted
the implementation of Indian Public Health Standards (IPHS) for Ayushman Arogya Mandir (AAM)
and Ayush hospitals, with states expected to achieve 30% compliance by June 2026, 40% by 2028,
and 50% by 2029.
Dr. Mahesh Kumar Dadhich, CEO of the National Medicinal Plants Board (NMPB), outlined the vital
role of medicinal plants in conservation, biodiversity, and climate change mitigation under the
"Central Sector Scheme for Conservation, Development and Sustainable Management of Medicinal
Plants."
Dr. Saketh Ram Thrigulla presented on the Ayush Grid initiative, a dedicated Digital Health Platform
that aims to transform operational efficiency and service delivery in the Ayush sector.
Representatives from Kerala, Uttar Pradesh, Telangana, Bihar, Manipur, and Andaman & Nicobar
Islands shared their respective best practices and innovations in Ayush healthcare delivery.
Session V focused on "Regulatory Mechanism with Respect to Quality Assurance of Ayush Medicines
and Monitoring of Misleading Advertisements," coordinated by Dr. Raman Kaushik. The session
addressed the challenges in uniformly implementing regulatory provisions across states and the
need for strengthened coordination between central and state authorities. Dr. Galib from AIIA,
Delhi, discussed strategies for monitoring misleading advertisements through the
Pharmacovigilance program. Representatives from Gujarat, Assam, Karnataka, and Tamil Nadu
presented their best practices in regulatory compliance and quality assurance.
The final session of the day explored "Investment Opportunities in Ayush Sector," coordinated by
Shri Indroneel Das from Invest India. Dr. Suruchi Mittar, Sr. Vice-President & CIO, Invest India,
highlighted the sector's remarkable growth from USD 2.85 billion in 2014 to USD 23 billion by 2023
in manufacturing, with an ambitious target of USD 200 billion by 2030.
Highlights of the Day-1
The NAM Conclave 2025 commenced on May 1 with the participation of several State and UT
Ministers, including Dr. Prem Chand Bairwa, Deputy Chief Minister of Rajasthan; Dr. Dayashankar
Mishra 'Dayalu' from Uttar Pradesh; Shri Shyam Bihari Jaiswal from Chhattisgarh; Shri Yadvinder
Goma from Himachal Pradesh; Smt. Pi Lalrinpuii from Mizoram; and Shri G.T. Dhungel from Sikkim.In his inaugural address, Shri Prataprao Jadhav, Union Minister of State (Independent Charge) for
Ayush and Minister of State, Ministry of Health and Family Welfare, Government of India,
highlighted that the number of beneficiaries of Ayushman Arogya Mandir (Ayush) has risen
dramatically from 1.5 crore in 2021 to more than 11.5 crore in 2025. Vaidya Rajesh Kotecha,
Secretary, Ministry of Ayush, noted that the NAM budget has increased from ₹78 crore in 2014 to
₹1275 crore in 2025-26.
Dr. Dayashankar Mishra from Uttar Pradesh reported that the state currently has 3,959 operational
Ayush hospitals with varying bed capacities. Shri Prem Chand Bairwa mentioned that Rajasthan is
preparing a comprehensive Ayush policy for integrated growth of all Ayush systems, while Shri
Yadvinder Goma highlighted Himachal Pradesh's integrated model combining traditional knowledge
with modern technology.
Dr. Atul Mohan Kocchar, CEO of NABH, emphasized the importance of accreditation in enhancing
trust and regulatory compliance in Ayush facilities. The session also featured insights from
specialized institutions like the National Homoeopathy Research Institute in Mental Health
(NHRIMH) and the Institute of Applied Dermatology (IAD). Representatives from Andhra Pradesh,
Punjab, Tripura, and Maharashtra shared their initiatives to attract investments in the Ayush sector.
Ms. Kavita Garg, Joint Secretary, Ministry of Ayush, shared additional key achievements: "5.6 crore
beneficiaries have availed services at Ayush tertiary care institutions. NABH entry-level certification
for 1,372 Ayush Health and Wellness Centres, and the establishment of 189 Integrated Ayush
Hospitals reflect our commitment to quality and accessibility."
A key highlight of Day-1 was the release of Standard Treatment Guidelines (STGs) on Metabolic
Disorders in Ayush Systems of Medicine, covering five major metabolic disorders—Diabetes
Mellitus, Obesity, Gout, Non-Alcoholic Fatty Liver Disease (NAFLD), and Dyslipidemia.
The conclave continues to serve as a vital platform for knowledge exchange, policy discussions, and
collaborative planning to further strengthen the Ayush healthcare system across India.
About National Ayush Mission
The National Ayush Mission (NAM), launched in 2014, plays a crucial role in preserving and
promoting India's traditional systems of medicine and their integration into the mainstream
healthcare system. It aims to enhance the availability, accessibility, and quality of Ayush healthcare
services across the country through Ayushman Arogya Mandir (Ayush) as part of the Government
of India's Ayushman Bharat scheme.
* * *
PIB Mumbai | A.Chavan/D.Rane
(Release ID: 2126244)